OUR PLATFORM TECHNOLOGY
We are focused on enhancing treatments in a range of therapy areas using our microneedle patches to deliver medicines, vaccines and aesthetics through the skin.
We customise the design and manufacture of our microneedle patches through 3D precision printing.
OUR PLATFORM ADVANTAGES
Our microneedle patches can offer several advantages due to our unique, patented and proprietary manufacturing technology. We custom design microneedles to optimise the delivery of your molecule. The benefits of our technology include:
ADAPTABLE TO MOLECULES
Combine with a wide range of active pharmaceutical ingredients (APIs) and vaccines for many different therapy areas.
OPTIMISED DELIVERY PROFILES
High dose, immediate or extended-release options are possible, dependent on your target product profile.
We can adjust microneedle size, patch shape and design to meet your product needs and patient preferences.
SHORT WEAR TIME
With a taregt wear time of 5 minutes or less, our microneedle patch may help to improve treatment compliance and patient experience.
Rapidly integrate and upscale production of your product at high volume and low cost.
Our fully automated production line, established for Radara®, meets key manufacturing quality standards.
An alternative delivery solution to scarce vials and needles that could reduce vaccine & medicine wastage and requires less transport.
By combining with evolving digital health technology, we may support future self-administration of treatments in the home.
OUR MICRONEEDLE TYPES
A layer of treatment is placed on each individual microneedle, enabling vaccines or medicines to be applied into the skin in a single step.
A single component product, where the microneedle structure contains the treatment within a matrix that, on application, dissolves into the skin.
A two-part system. The microneedle patch is applied to the skin, creating channels that allow a separately applied topical to have an accelerated effect.
We work collaboratively and use our expertise to advise our partners on the right type of microneedle technology for their molecule, helping to build a new custom designed product.
OUR MANUFACTURING PROCESS
Ease of production is a founding principle of our company; our manufacturing techniques are more efficient, and we have readily available machinery. We are working towards our goals of ISO9001 accreditation in 2021.
1. Building Our STERILE Microneedles In Layers
We begin by building our microneedles in layers on top of a backing material. This enables us to adapt microneedle height, width and shape to create your target product profile.
Our microneedles are made with UV-curable biocompatible polymers to reduce the risk of side effects. In the longer term we are also developing new polymers to improve performance and increase sustainability.
2. SIMULTANTEOUS & CONTINUOUS MANUFACTURE OF Our Microneedles
A continuous, highly accurate and efficient manufacturing line simultaneously creates ergonomic patch sizes established through long-term manufacturing of Radara®.
High volume manufacturing with a small footprint can produce +250 million patches per annum, per line.
We use a defined and unique wave-light range (Ultraviolet) to cure and sterilise our microneedles. This low-temperature method reduces the risk of damage to the patch. It also enables us to efficiently and continuously manufacture along a single production line.
3. COATING OUR MICRONEEDLE WITH OUR FORMULATION WITH YOUR MOLECULE
Individual microneedles are coated using the same processes and machinery to ensure accurate, efficient and consistent dosing.
Innoture’s adaptable base formulation is applicable to a range of molecules and can be optimised for your molecule.
Patch size alterable for high doses, treatment titration and multi-treatment option.
PARTNER WITH US
We welcome discussions with potential industry, academic and NGO partners as to how we can combine your molecule with our technology to make a meaningful difference to patient and public health.
Do get in touch if you would like to join us on this journey.